Mallinckrodt Plc Ordinary Share (MNK) 116.72 $MNK Why

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mallinckrodt Plc Ordinary Share (MNK) 116.72 $MNK

Why Mallinckrodt (MNK) Could Beat Earnings Estimates Again - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 27, 7:59AM CST
Mallinckrodt has a nice short-term history of crushing expectations, and could be a great candidate for another beat
MNK: 116.72 (-2.89)

The Top Mid-Cap Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Fri Feb 27, 2:04AM CST

SIRO: 90.82 (-0.20), JCOM: 67.25 (-0.66), SKX: 68.14 (-0.62), CIEN: 20.92 (+0.01), NUVA: 45.75 (+0.76), LII: 104.26 (-0.02), WWW: 30.56 (+0.34), SIVB: 122.90 (-1.01), CSL: 93.07 (-1.11), DLX: 66.55 (-1.40), MNK: 116.72 (-2.89), CAVM: 68.49 (+0.09), CBL: 20.02 (+0.17), EV: 42.10 (+0.49), IMAX: 34.97 (-0.04), WWAV: 40.95 (+0.07), CBRL: 151.03 (+0.01), PRXL: 64.46 (-0.80), KNX: 33.06 (-0.11), HAE: 44.46 (-0.79), TFX: 121.69 (+0.47), FLO: 21.64 (+0.21), FHN: 14.29 (-0.18), BIG: 47.71 (-0.02), NVR: 1,332.00 (-8.98), WEN: 11.09 (-0.22)

FDA accepts Teva's NDA for abuse-deterrent opioid
Seeking Alpha - at Seeking Alpha - Wed Feb 25, 8:42AM CST

MNK: 116.72 (-2.89), LCI: 62.40 (-2.77), ACT: 291.36 (+1.58), EGLT: 15.01 (+0.03), ZGNX: 1.68 (+0.03), PFE: 34.32 (-0.27), ABBV: 60.50 (-0.02), TEVA: 57.02 (+0.53), ALKS: 70.25 (-0.98), ACUR: 0.85 (+0.09)

Lannett Joins Big-Game Hunt For Drugmaker Acquisitions
at Investor's Business Daily - Tue Feb 24, 2:58PM CST
Generic-drug maker Lannett Co. in recent quarters has surged on price increases and, more recently, volume gains on key prescription medications. Like some other drug companies in the news this week, Lannett (LCI) is on the hunt for potential...
AGN: 232.74 (+0.34), MNK: 116.72 (-2.89), LCI: 62.40 (-2.77), VRX: 197.48 (-3.77), ACT: 291.36 (+1.58), AKRX: 53.81 (+0.34), SHPG: 241.91 (-5.93), SLXP: 157.20 (+0.25), NPSP: 45.97 (+0.01), MYL: 57.33 (+0.09), BMY: 60.92 (-0.54)

Mallinckrodt: Strong Growth From Transformative Acquisitions Paying Off
Brad Kenagy - at Seeking Alpha - Tue Feb 24, 6:22AM CST

MNK: 116.72 (-2.89)

Five Top-Rated Medical Stocks To Keep Monitoring
at Investor's Business Daily - Mon Feb 23, 5:22PM CST
Most Stock Spotlight names are well extended past proper buy points as the market improves, but it doesn't hurt to keep watching them for a new opportunity to buy. Two generic drugmakers on the list, Akorn (AKRX) and Mallinckrodt (MNK), are extended....
MNK: 116.72 (-2.89), LCI: 62.40 (-2.77), ACT: 291.36 (+1.58), AKRX: 53.81 (+0.34), MYL: 57.33 (+0.09)

Tracking John Paulson's Paulson & Company Portfolio - Q4 2014 Update
John Vincent - at Seeking Alpha - Mon Feb 23, 3:36AM CST

TLM: 7.78 (+0.05), HHC: 149.79 (+1.59), AET: 99.55 (+0.24), STAY: 19.30 (-0.24), DLTR: 79.68 (+0.64), AEM: 32.15 (+0.04), NPSP: 45.97 (+0.01), DG: 72.62 (+0.43), ABBV: 60.50 (-0.02), TMUS: 33.03 (+0.55), DXM: 6.75 (-0.02), CODE: 36.08 (-0.11), MNK: 116.72 (-2.89), GOLD: 79.19 (+0.19), NCQ: 0.60 (+0.01), COV: 106.71 (-1.36), AU: 11.27 (+0.11), SLXP: 157.20 (+0.25), IAG: 2.45 (+0.09), MYL: 57.33 (+0.09), FDO: 78.74 (+0.13), MGM: 21.73 (-0.22), HIG: 40.96 (-0.03), NG: 3.72 (+0.07), EQIX: 224.18 (-2.22), OAS: 14.33 (-0.23), PETM: 82.91 (+0.01), ACT: 291.36 (+1.58), MDT: 77.59 (-1.22), BPOP: 34.51 (+1.77), ENZY: 8.29 (+0.11), GFI: 4.65 (+0.04), CZR: 10.60 (-0.19), CVC: 18.78 (-0.10), CIE: 10.24 (+0.43), AGN: 232.74 (+0.34), CACQ: 7.39 (-0.13), T: 34.56 (+0.06), ECA: 13.05 (-0.03), S: 5.12 (+0.35), FCH: 10.77 (+0.12), SHPG: 241.91 (-5.93), DTV: 88.60 (+0.25), KMDA: 4.51 (-0.01), ANV: 1.00 (-0.03), BAC: 15.81 (-0.23), GRFS: 32.76 (-0.55), HCA: 71.54 (-0.73), POST: 49.48 (unch), RDN: 15.81 (-0.14), BEE: 13.12 (unch), GLD: 116.16 (+0.09), RLGY: 46.00 (-0.47), HMHC: 19.78 (-0.28), MTG: 9.13 (unch), CMCSA: 59.38 (+0.23), SBGL: 10.59 (+0.17), BABA: 85.12 (-0.25)

The Top Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Mon Feb 23, 2:37AM CST

ELLI: 52.85 (-0.39), JCOM: 67.25 (-0.66), CAH: 87.99 (-0.18), CIEN: 20.92 (+0.01), AET: 99.55 (+0.24), ANAC: 43.50 (-0.60), CSL: 93.07 (-1.11), HSIC: 140.05 (-0.39), MNK: 116.72 (-2.89), CAVM: 68.49 (+0.09), HAS: 62.31 (-0.19), BCR: 169.14 (-1.80), MCHP: 51.27 (-0.20), MYL: 57.33 (+0.09), DEPO: 21.95 (-0.65), HRL: 58.51 (+0.05), CSX: 34.31 (unch), DYAX: 15.11 (-0.37), LVLT: 53.86 (+0.47), CBRL: 151.03 (+0.01), MTSI: 33.72 (-0.27), AZO: 642.68 (-2.29), KNX: 33.06 (-0.11), HAE: 44.46 (-0.79), FSL: 36.11 (+0.14), BDX: 146.72 (-1.82), ACT: 291.36 (+1.58), BLL: 71.71 (-0.71), NUVA: 45.75 (+0.76), CDW: 37.63 (-0.54), ADBE: 79.10 (+0.14), AFFX: 11.70 (-0.03), AGN: 232.74 (+0.34), ANTM: 146.45 (-0.27), APH: 56.46 (-0.34), INFA: 42.94 (-0.51), EXAM: 40.40 (-0.20), LII: 104.26 (-0.02), CNMD: 51.30 (+0.04), BJRI: 52.22 (-0.10), DLX: 66.55 (-1.40), ABT: 47.37 (-0.24), ENDP: 85.60 (+0.36), ABCO: 54.12 (-0.43), DIOD: 28.49 (-0.30), LEG: 45.05 (-0.03), DIS: 104.08 (-0.48), GLW: 24.40 (-0.07), MAR: 83.10 (-0.12), IMAX: 34.97 (-0.04), CNC: 61.46 (+0.28), IGV: 98.31 (-0.43), CTAS: 83.48 (-0.53), FLT: 153.43 (-1.98), CMCSA: 59.38 (+0.23), FLO: 21.64 (+0.21), CRM: 69.38 (-0.86)

10 Stocks John Paulson Loves: Allergan, Time Warner Cable and More
at The Street - Thu Feb 19, 7:46AM CST
Here's a closer look at 10 stocks Paulson & Co. bought in the most recently reported quarter.
MNK: 116.72 (-2.89), AGN: 232.74 (+0.34), WLL: 33.83 (-0.17), ACT: 291.36 (+1.58), TLM: 7.78 (+0.05), SLXP: 157.20 (+0.25), DTV: 88.60 (+0.25), MYL: 57.33 (+0.09), TWC: 154.05 (+1.65), TMUS: 33.03 (+0.55)

Actavis Tops Views, Announces Name Change To Allergan
at Investor's Business Daily - Wed Feb 18, 4:34PM CST
Irish drugmaker Actavis topped quarterly sales and profit views Wednesday and said that it will change its corporate name to better reflect its transition from a provider mostly of generic drugs to a branded pharmaceutical firm. The Dublin-based...
MNK: 116.72 (-2.89), AGN: 232.74 (+0.34), LCI: 62.40 (-2.77), ACT: 291.36 (+1.58), AKRX: 53.81 (+0.34)

Elite Pharma set to begin abuse-deterrent opioid Phase 3 trial
Seeking Alpha - at Seeking Alpha - Tue Feb 17, 9:06PM CST

MNK: 116.72 (-2.89), LCI: 62.40 (-2.77), EGLT: 15.01 (+0.03), ACT: 291.36 (+1.58), ZGNX: 1.68 (+0.03), PFE: 34.32 (-0.27), ABBV: 60.50 (-0.02), TEVA: 57.02 (+0.53), ALKS: 70.25 (-0.98), ACUR: 0.85 (+0.09)

FDA accepts Collegium's NDA for abuse-deterrent opioid
Seeking Alpha - at Seeking Alpha - Tue Feb 17, 7:40AM CST

MNK: 116.72 (-2.89), LCI: 62.40 (-2.77), EGLT: 15.01 (+0.03), ACT: 291.36 (+1.58), ZGNX: 1.68 (+0.03), PFE: 34.32 (-0.27), ABBV: 60.50 (-0.02), TEVA: 57.02 (+0.53), ALKS: 70.25 (-0.98), ACUR: 0.85 (+0.09)

The Best Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Sun Feb 15, 1:02PM CST

OCR: 76.74 (-0.07), ELLI: 52.85 (-0.39), CAG: 34.98 (+0.31), JCOM: 67.25 (-0.66), CAH: 87.99 (-0.18), AET: 99.55 (+0.24), PKG: 82.86 (+0.15), CAKE: 47.52 (-1.13), DAN: 21.85 (-0.17), CSL: 93.07 (-1.11), AAN: 29.81 (+0.14), HSIC: 140.05 (-0.39), MNK: 116.72 (-2.89), CAVM: 68.49 (+0.09), HAS: 62.31 (-0.19), BCR: 169.14 (-1.80), MCHP: 51.27 (-0.20), COLM: 55.89 (-0.13), NXPI: 84.89 (-0.07), CSX: 34.31 (unch), LVLT: 53.86 (+0.47), PFPT: 56.64 (-0.69), AZO: 642.68 (-2.29), IRWD: 15.45 (-0.58), HAE: 44.46 (-0.79), EL: 82.67 (+0.39), FSL: 36.11 (+0.14), ACT: 291.36 (+1.58), BDX: 146.72 (-1.82), BLL: 71.71 (-0.71), BWLD: 191.12 (-0.62), NUVA: 45.75 (+0.76), CDW: 37.63 (-0.54), AFFX: 11.70 (-0.03), AGN: 232.74 (+0.34), DPS: 78.79 (+0.60), APH: 56.46 (-0.34), INFA: 42.94 (-0.51), EXAM: 40.40 (-0.20), GMED: 24.28 (-0.78), LII: 104.26 (-0.02), CNMD: 51.30 (+0.04), BJRI: 52.22 (-0.10), HBI: 127.54 (-1.37), DLX: 66.55 (-1.40), ORLY: 208.13 (-1.21), DIOD: 28.49 (-0.30), LEG: 45.05 (-0.03), DIS: 104.08 (-0.48), GLW: 24.40 (-0.07), DISH: 75.04 (-1.72), LEA: 108.92 (-0.11), IMAX: 34.97 (-0.04), CNC: 61.46 (+0.28), PERY: 23.60 (+0.02), CTAS: 83.48 (-0.53), BIG: 47.71 (-0.02)

European Optimism Defies Greece, Ukraine And GDP Views
at Investor's Business Daily - Fri Feb 13, 4:45PM CST
Markets in Europe finished Friday with modest gains for the week after navigating a rush of historic news events. Those events involved another cease-fire in Ukraine's civil war, talks regarding the status of Greece's bailout and fourth-quarter GDP...
MNK: 116.72 (-2.89), CRH: 28.31 (+0.14), KING: 15.79 (-0.16)

FDA accepts Pfizer's NDA for abuse-deterrent opioid
Seeking Alpha - at Seeking Alpha - Fri Feb 13, 10:22AM CST

MNK: 116.72 (-2.89), LCI: 62.40 (-2.77), ACT: 291.36 (+1.58), ZGNX: 1.68 (+0.03), PFE: 34.32 (-0.27), ABBV: 60.50 (-0.02), TEVA: 57.02 (+0.53), ALKS: 70.25 (-0.98)

Anika Therapeutics files Cingal regulatory apps in U.S. and Europe
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 2:42PM CST

MNK: 116.72 (-2.89), FLXN: 22.81 (-0.08), XENE: 19.34 (+0.29), HZNP: 20.53 (+1.46), AMPE: 5.64 (-0.02), CBYL: (), ANIK: 39.92 (-0.04)

6 Big Pharmaceutical Companies You Don't Want In Your Portfolio
at The Street - Tue Feb 10, 7:17AM CST
Which big pharmaceutical stocks should investors stay away from in 2015?
MNK: 116.72 (-2.89), ENDP: 85.60 (+0.36), JAZZ: 170.09 (-5.10), AZN: 68.90 (-0.11), SLXP: 157.20 (+0.25), GSK: 47.42 (-0.42)

Healthcare stock screen of the month: Accelerating after-tax margins
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 11:21AM CST

MNK: 116.72 (-2.89), BIIB: 409.59 (-0.51), VRX: 197.48 (-3.77), BCR: 169.14 (-1.80), EVHC: 36.62 (-0.93), TMO: 130.00 (-0.14), CAH: 87.99 (-0.18), UTHR: 155.05 (-0.53), ILMN: 195.46 (-3.00), ACOR: 33.84 (-1.72), LCI: 62.40 (-2.77), JAZZ: 170.09 (-5.10), SHPG: 241.91 (-5.93), CPHD: 56.84 (-1.60), SYK: 94.75 (+0.35)

Analysts remain bullish on Mallinkrodt
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 12:13PM CST

MNK: 116.72 (-2.89)

Texas AD investigating Mallinckrodt Medicaid pricing
Seeking Alpha - at Seeking Alpha - Wed Feb 04, 9:34AM CST

MNK: 116.72 (-2.89)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Why Buyers Are Flocking to Whidbey Island Homes

Updated Category News Views 1

Something's got folks eyeing Whidbey Island like a gambler with a hot tip—and it ain't just the thrill of a vacation spot. Anyone with half a brain knows real estate moves in waves, and right now, Whidbey Island's caught some serious momentum. You can't ignore the pull of natural beauty, access to city life, and that laid-back vibe that seems to whisper "slow down and...

Continue Reading
Patented Foodservice Firm's $1.6M Sale: High ROI Potential

Updated Category News Views 1

Cooking Up High Margins and Rapid Growth You don’t stumble on opportunities like this every day. A foodservice company out there is posting some mouth-watering numbers, and it’s shaking up the M&A scene. This one’s got patents holding up its brand like a culinary force field, and it’s now on the auction block for a cool $1.6 million. And the numbers? Well, they...

Continue Reading
Court Enforces Design Rights: AEKE Blocked in Germany

Updated Category News Views 11

Court's Verdict: A Lesson in Design Protection Right out the gate, the Cologne Regional Court didn't pull any punches. Speediance got their 'Gym Monster' design yanked from under AEKE over in Germany. Legal swords were drawn after Speediance spotted AEKE's fitness gear looking a bit too familiar at the FIBO trade fair. Somebody should've told AEKE that a tapped shoulder...

Continue Reading
PrimeBOT Shines at IFA 2026 with Innovative Awards

Updated Category News Views 6

A New Chapter in Home Robotics In today's tech-centric world, newcomers often confuse flash with substance. But every now and then, you catch a glimpse of something that might just change how the world spins. At this year's IFA 2026, PrimeBOT didn't just dip its toes into the limelight—it cannonballed right in, drumming up some serious buzz with its PrimeBOT T1 and...

Continue Reading
Testing Grounds: Navigating PRN Test Insights

Updated Category News Views 1

Deciphering the PRN Tester Repetition Today we're staring at what feels like déjà vu—a simple PR test peppered with the classic sentence about a fox and a dog. It's like someone left the 'repeat' function stuck on during a slow day at the office. But hey, let’s dig in. Is there something more behind this repetitive text, or are we grumbling at a wall? Unpacking the...

Continue Reading
Softcare Facilitates Standards Delegation Visit to Senegal

Updated Category News Views 0

Ever seen a whole nation's hygiene industry getting a deep dive from not just one, but three major standards bodies? That's what just went down in Senegal. Softcare opened its doors wide to folks from the Senegalese Association for Standardization (ASN), the International Organization for Standardization (ISO), and the Swedish Institute for Standards (SIS). This was no...

Continue Reading
Penetron Strengthens Midwest, Central USA Support Team

Updated Category News Views 3

Expansion of Penetron's Engineering Support Eyes are on the Midwest and Central USA as Penetron makes a strategic move to bolster their technical support dream team. They've snagged Sean Allison, a heavyweight with more than three decades' worth of grit and know-how from the construction battlefield. Sean, now stationed in the heart of America's Dairyland—Green Bay,...

Continue Reading
TECNO's Modular Phone and Mini-PC Win Big at IFA 2026

Updated Category News Views 1

The Tale of Two Game-Changers TECNO has just scooped up two big-time awards, and I'm here to break it down like no glossy magazine ever could. Picture this: a brand that knows how to keep its foot on the innovation pedal and doesn't shy away from shaking up the tech world. TECNO's got the goods, claiming two prestigious IFA Global Product Technology Innovation Awards this...

Continue Reading
TCL Drives Fan Experience at FIBA Women's World Cup

Updated Category News Views 5

TCL's Slam Dunk on the Global Stage The FIBA Women's Basketball World Cup 2026 in Berlin is set to showcase some incredible talent, and TCL is right in the thick of it. As a FIBA Global Partner, they're spearheading a new wave of fan interactions with their TCLforHer initiative, focusing on tech-enabled fan experiences that go beyond just watching the game. This isn't...

Continue Reading
Consumer365 Lauds Happy Head's Custom Hair Treatments

Updated Category News Views 6

Revolutionizing Hair Loss Treatment The world of hair growth solutions is transforming right before our eyes. Thanks to the folks over at Happy Head and their customizable, dermatologist-prescribed treatments, the days of one-size-fits-all are ending. Consumer365 recently took a dive into Happy Head's model, giving their nod of approval to its personalized approach....

Continue Reading

Top 5 Most Recently Viewed Articles

Consumer Spending Fuels Economic Growth Amid Challenges

Updated Category News Views 216

Riding the Rollercoaster of Consumer Confidence Consumer confidence these days is like a tightrope walk—balancing between optimism and caution. Recent data paints a complex picture: while some economic indicators hint at recovery, many folks are still walking around with worry etched on their faces. Decoding Confidence Metrics The main players in this confidence drama...

Continue Reading
Explore New Horizons at the China International Hardware Show

Updated Category News Views 144

China International Hardware Show 2025: A Gateway to Opportunities As the landscape of global commerce evolves, events like the China International Hardware Show (CIHS) provide a vital platform for industry stakeholders. Even in uncertain times, the CIHS 2025 demonstrates resilience and innovation, drawing participation from a multitude of global brands eager to showcase...

Continue Reading
Examining McDonald's Stock Growth Over Two Decades

Updated Category News Views 36

Understanding McDonald's Stock Growth Over the last two decades, McDonald's (NYSE: MCD) has presented an impressive financial performance that is worth discussing. The fast-food giant has outpaced the market by an annualized rate of 3.81%, culminating in an average annual return of 12.02%. This remarkable achievement reflects not only the company’s resilience but also...

Continue Reading
Entrepreneurship with Meaning: Explore Grasons' Impactful Ventures

Updated Category News Views 113

Empowering Entrepreneurs with Grasons The concept of starting a business has always been close to the heart of many aspiring entrepreneurs. In today's landscape, where transitions in life can lead to both challenges and opportunities, numerous individuals are turning to Grasons. This business model not only aids families during significant changes but also offers a path...

Continue Reading
Innovations Driving Sustainability in the Synthetic Paper Sector

Updated Category News Views 162

Emerging Trends in the Synthetic Paper Market The global synthetic paper market is on an exciting growth path, projected to reach a notable valuation within a few years. This increasing demand is largely driven by the need for durable and environmentally friendly packaging options across various industries such as food and beverage, pharmaceuticals, and outdoor products....

Continue Reading